Abstract
Nanotechnology deals with materials that are 1–100 nm in size.
Nanomaterials are prepared in different ways such as physical, chemical, and biological
methods. They exhibit fascinating features that allow them to perform numerous
physiological tasks. They have higher surface area to volume ratios and show typical
nanoscale quantum confinement characteristics. They play a critical role in biomedical
research. They're quite versatile and used in a variety of medical applications. The
demand for nanomedicine drugs with improved performance and reduced toxicity has
been steadily increasing in recent years. Nanomedicine is the new area of nanoscience
and nanotechnology. Pharmaceutical nanosystems are classified, synthesized, and
characterized using procedures based on their size, shape, and functionality. This book
chapter focuses on recent trends of nanomedicine technology in pharmacology,
particularly on the application of nanomaterials in medicine. Antibacterial
characteristics, multicolor medical imaging, disease diagnostics, medication
administration, vaccines and biomolecules (peptides, proteins, and genes), therapies,
cancer treatment, tissue engineering, and clinical aspects are discussed. Advancements
in nanomedicine technology will not only aid in the early diagnosis of infectious and
viral disorders, but also in the treatment of infections such as Alzheimer's disease,
tuberculosis, and Parkinson's disease. The benefits and constraints of commercializing
nanomedicine technology products for pharmacology applications, as well as the
hazards and obstacles in developing nanomaterials for medical research are highlighted
in this chapter.